AKTS

Aktis Oncology INC

+$620.9M

Net Activity

Institutions Holding

69

Popularity Rank

#5257

Avg Weight

0.52%

Total Value

$620.9M

Ownership Trend

69 institutions currently hold AKTS, with 66 net buyers and 0 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Significantly Increased

Based on recent trading activity

Net Selling Institutions

0

Net Buying Institutions

66

Key Holders

Key Holders

Top 5 by Value

MB
Mpm Bioimpact LLC
$86.5M
EC
EcoR1 Capital, LLC
$86.3M
BO
Blue Owl Capital Holdings LP
$56.6M
WM
Wellington Management Group LLP
$41.5M
TR
T. Rowe Price Investment Management, Inc.
$38.0M

Top 5 by Conviction

BO
Blue Owl Capital Holdings LP
15.20%
MB
Mpm Bioimpact LLC
6.68%
M&
Merck & Co., Inc.
4.88%
EC
EcoR1 Capital, LLC
3.66%
OC
Octagon Capital Advisors LP
1.90%
View all 69 holding institutions

Quarterly Activity

Recent Activity

+$601.6M

Total Buy Value

$0.0

Total Sell Value

New buy66
Trim0
Add0
Sold out0

66

Net Buyers

0

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

2

Filings (90d)

$2.78M

Total Est. Value

100K shares

Planned Shares

Last Filed 2026-07-08
FilerFiling DateEst. Value
AKOS CZIBERE2026-07-08$1.39M
SHULAMIT RON-BIGGER2026-07-08$1.39M

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding AKTIS ONCOLOGY INC (AKTS)?
Major stakeholders currently include Mpm Bioimpact LLC ($86.5M), EcoR1 Capital, LLC ($86.3M), Blue Owl Capital Holdings LP ($56.6M). Based on the latest 13F filings, there are a total of 69 tracked investment funds and institutions maintaining positions in AKTS.
What is the overall institutional sentiment toward AKTS recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $620.9M, driven by 66 managers accumulating shares while 0 reduced their exposure.
Which institutions have been selling or reducing their AKTS positions?
In the latest period, no tracked funds trimmed or exited their positions in AKTS.
Are there any notable investors adding AKTS to their portfolios?
Yes, buying activity remains notable. 66 institutions opened new positions in {ticker}, and 0 existing holders added to their shares. The total reported buy value for the quarter amounted to $601.6M.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail